Drugs / monofluorophosphate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01589458 | Aug 2011 → Feb 2012 | dental caries | University of Campinas, Brazil | Completed | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 3 | NCT03852056 Comparator | May → Dec 2017 | gingivitis | Colgate Palmolive | Completed | No outcome recorded |
| Phase 3 | NCT00759187 Comparator | Jan → Apr 2008 | gingival disorder | Colgate Palmolive | Completed | No outcome recorded |
| Phase 4 | NCT04033575 Comparator | Mar → Jun 2019 | gingivitis | Colgate Palmolive | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | monofluorophosphate | “0.76% monofluorophosphate (1000 ppm MFP), Colgate Cavity Protection toothpaste is a control treatment.” NCT04033575 ↗3“Fluoride Availability in Saliva After Use of Sodium Fluoride or Monofluorophosphate Toothpastes” NCT01589458 ↗ “Commercially available, monofluorophosphate (MFP) toothpaste. Fluoride level is 0.76%” NCT03852056 ↗ “monofluorophosphate” NCT00759187 ↗ |
| Known as | MFP | “Considering the widespread use of sodium fluoride (NaF) and monofluorophosphate (MFP) based toothpastes, the present study aim to evaluate F availability in saliva after use of...” NCT01589458 ↗1“Commercially available, monofluorophosphate (MFP) toothpaste. Fluoride level is 0.76%” NCT03852056 ↗ |
| Route | Oral | “Brush twice daily” NCT00759187 ↗ |